BENZENO SHARON plan to sell securities of Adaptive Biotechnologies Corp under Form 144

BENZENO SHARON filed Form 144 to notify SEC of plan to sell 63103 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $916,255.56. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.04% of total outstanding units;